Episodes
Friday Jan 19, 2024
Friday Jan 19, 2024
Over 75% of heart failure with preserved ejection fraction (HFpEF) patients have a comorbid diagnosis of obesity. Obesity is an independent risk factor for the development of HFpEF and contributes to disease progression. Obese patients with HFpEF have greater symptom burden, reduced functional capacity, and impaired quality of life when compared to those without obesity. We know that patients often struggle to adhere to lifestyle modifications long enough to see meaningful weight loss, but the benefits of GLP-1 agonists for patients with HFpEF who are obese are not yet clear.
Guest Authors: Alicia M. Nordberg-Payne, PharmD; Rebecca Munger, PharmD, BCACP; Jason Zupec, PharmD, BCACP
Music by Good Talk
Saturday Feb 18, 2023
Top Ten Things Every Clinician Should Know About Treating Obesity
Saturday Feb 18, 2023
Saturday Feb 18, 2023
Obesity is a chronic, progressive, multi-factorial, neurobehavioral disease characterized by excessive adipose tissue. Here are some things every clinician should know about treating overweight and obesity but be sure to read the written commentary posted on iForumRx.org
Guest Authors: Jennifer N. Clements, PharmD, BCPS, BCACP, CDCES, BC-ADM and Seena L. Haines, PharmD., BCACP, NBC-HWC, CHWC
Music by Good Talk
Friday Jul 16, 2021
STEP-ping Up the Game for Weight Management
Friday Jul 16, 2021
Friday Jul 16, 2021
More than two-thirds of adults in the United States are overweight or obese — thus, obesity is, by far, the most common preventable health-related problem seen in practice today. Obesity is associated with several comorbidities, and weight reduction leads to positive outcomes in many diseases. Studies have shown that a weight loss of 10% improves cardiovascular risk and outcomes. Unfortunately, current pharmacological options for weight loss do not consistently achieve a 10% weight loss. Can semaglutide deliver?
Guest Panelists: Teney Mathew, PharmD, Jason Zupec, PharmD, BCACP, and Amy Heck Sheehan, PharmD, BCPS
Music by Good Talk
Friday Jul 15, 2016
Preventing Weight Gain - Recommending Behavior Change in Young Adults
Friday Jul 15, 2016
Friday Jul 15, 2016
We're all aware that there is an obesity epidemic and its linked to dozens of health problems. But nothing we've done so far — public awareness campaigns, changes in school lunch programs, and approving new drugs for weight loss — has halted this epidemic. The prevalence of obesity continues to climb in young adults and most of us keep packing on the pounds as we get older! Thus preventing weight gain in young adults is critically important to long-term outcomes. The recent results of the Study of Novel Approaches to Weight Gain Prevention (SNAP) provides evidence to guide recommendations for behavioral change.